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Abstract
Clay has its widespread applications in pharmaceuticals from ancient world to 
modern era. It is one of the excellent excipients present in the commercially avail-
able pharmaceuticals. Its use in many of dosage forms viz. in suspension, emulsion, 
ointments, gels, tablet and as drug delivery carrier as suspending agent, emulsify-
ing agent, stiffening agent, binder, diluent, opacifier, and as release retardant have 
been explored in many studies. Variety of minerals is used as both excipient and as 
an active ingredient; among that kaolinite, talc, and gypsum are important. Their 
inertness, low toxicity, versatile physiochemical properties and cost effectiveness 
has increased its usage in pharma industries. Many minerals have its own pharma-
cological action as antacid, anti-bacterial, anti-emetic, anti- diarrheal agent and 
as skin protectant etc. Their unique structure which helps them to absorb material 
onto their layered sheets has opened a wide variety of applications in drug delivery. 
The understanding of surface chemistry and particle size distribution of clay min-
erals has led the pharmaceutical field in many directions and future perspectives.
Keywords: pharmaceutics, active pharmaceutical ingredient, excipients, inherent 
medicinal properties, drug delivery carrier, synergistic effect
1. Introduction
Usage of clay in medicine dates back to prehistorian era. Their evidences are 
present throughout the history from the clay pots of Nippur, Mesopotamia which 
gave the evidence of using clay against hemorrhages, the book “papyrus ebers” dat-
ing back in 1600 BC provided the details of using clay-based medicine for certain 
diseases. Many vital information on medical clay is mentioned in “On Airs, Waters 
and Places” written by Hippocrates (460–377 BC). One of the notable healing clay 
used in medicine during early days is known as Armenian bole (bolus armenus). 
They are pharmacologically used for the treatment of diarrhea, dysentery, hemor-
rhage, even as an astringent in few cases. Avicena in his book “El Canon” classified 
various types of clay and their internal and external applications. He also men-
tioned their role in anti-poison treatment and rheumatic disorders. Even though 
their consumption has been subjected to lot of questions the practice of using 
medicinal and edible clay prevails till date for their curative and beneficial effects. 
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Their usage in pharmaceutical industry is invariable due to their versatile property; 
they are used in almost every formulation like tropical to oral and also as an excipi-
ent. As the scientific community grows, there have been many papers published to 
support the medicinal and curative benefits of clay minerals [1–8].
The important component of clay is the clay minerals but it also comprises of 
associated minerals, organic, and inorganic materials. Clay can be grouped based on 
the geological aspects such as
• Primary or residual clay






Each clay has their own properties to distinguish themselves from the other. The 
classification also extends based on their geometrical shape, arrangement, and their 
usage. The classifications are given below.
Based on the geometry of the clay, it has been classified into four major groups 





The variation is due to the arrangement of tetrahedral and octahedral sheets, 
where kaolinite group has one tetrahedral sheet arranged over one octahedral sheet 
S. No General formula Group Layer type 
1 Al2Si2O5(OH) Kaolinite-Serpentine 1:1 






4 (Mg,Fe,Al)3(Al,Si)4O10(OH)2.4H2O Vermiculite 2:1 
5 KAl2(Si3Al)O10(OH)2 Mica/Illite 2:1 






Subgroups of the clay.
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whereas two tetrahedral sheets arranged over one octahedral sheet in smectite group. 
In case of chlorite group, octahedral sheet is arranged adjacent to 2:1 layer. The clay 
minerals exhibit versatile properties such as high adsorption capacity, chemical inert-
ness, thixotropy, specific surface area, ion exchange capacity, less toxicity for oral 
administration, swelling property justifying their wide applications in pharmaceuti-
cal industries as excipient to enhance the physiochemical and organoleptic charac-
teristics of a drug. It also helps in aiding drug conservation, elaboration, liberation of 
drug into the organism. These are achieved by incorporating the clay minerals such 
as disintegrates, lubricants, opacifiers, binders, diluents, isotonic agent, anti-caking 
agents, emulsifying agent, desiccant, thickening agent, and flavor modulators. Apart 
from the pharmaceutical applications, clay minerals also possess a lot of pharma-
cological properties like anti-bacterial, anti-viral, anti-diarrheal, gastro-intestinal 
protector, skin protection, and a potent detoxifier. The future trend holds for the 
MDDS using nano-clay minerals due to their inertness and biocompatibility. More 
details about the pharmaceutical and pharmacological uses of clay minerals and their 
advancement in drug delivery system have been discussed in the following sections. 
Further the classification and usage of clay minerals is illustrated in Figure 1.
2. Use of clay as excipients
An excipient is an inert additive ingredient formulated along with active compound 
to enhance its organoleptic, physiochemical properties. Clay has been used for almost 
every type of excipients (Table 2). Though several investigations showed that clay 
interacts with the drug molecule conversely to the nature of excipients, the interaction 
may hinder the drug bioavailability inside the body. The co-administration of mont-
morillonite leads to the degradation of certain cardiovascular tonic [9], anti-inflam-
matory drug [10]. Similarly, palygorskite and sepiolite degraded hydrocortisone and 
dexamethasone [11, 12]. Certain clay also affects the chemical stability of diazepam. 
Drugs such as phenobarbital sodium, diazepam solution, and lansoprazole show inter-
action with magnesite. Bioavailabity of tetracycline, indomethacin, aspirin, aspartame, 
ampicillin, cephalexin, and erythromycin has been drastically affected by calcium 
rich minerals. Clay minerals has also shown tendency to affect the drug liberation by 
interacting with the drugs through various mechanisms. They have shown to affect 
the liberation of amphetamines, analgesics, antibiotics,  anxiolytics, solar protectors, 
and anti-histamines [13–16]. The adsorption of anti-histamines, antibiotics, atropine 
Figure 1. 
Classification and usage of clay minerals.
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sulfate, salicylate, hyoscyamine, hydrobromide, paracetamol, and chloroquine into 
periclase and brucite has been showed by Khalil et al. [15]. These interactions have 
been proven useful since they are used to retard drug release. So they aid in controlled 
drug release and improve the Tmax considerably.
2.1 Clay in biphasic liquid formulation
2.1.1 In suspension
Excipients are required in the biphasic system in order to obtain proper 
wetting and to maintain stability of the formulation. In order to overcome the 
Type of Excipient Clay minerals Drug used
As Diluent Kaolin, talc, sepiolite, 
smectite, Magnesite
Slim well tablet, Quantrim, Riclasip, Riboflavin 
hard gelatine capsule
As Binder Gypsum, hydroxyapatite, 
kaolin
Kaolin-Eudragit 30 in many tablets

















































Diclofenac sodium, chlorhexidine, gallic acid, 
promethazine
Ciprofloxacin, Ag-Nanoparticles of Tetracycline, 




















Application of clay minerals as excipient.
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hydrophobicity of the drug and to aid in dispersion, clay minerals are added to 
the suspension as wetting agent. Sulfur ointment is prepared by blending kaolin 
with sulfur dispersed in oil phase [17]. The usage of bentonite as a wetting agent 
in foundation creams is also documented [18]. The clay also helps to maintain the 
stability by acting as suspending and anti-caking agent. They prevent sedimenta-
tion, changes in dispersion property, and flocculation. The criteria of selection of 
suitable suspending agent depend on compatibility, appearance, source, cost, and 
pH tolerance. The properties of the suspending agent including high viscosity at low 
shear rate, temperature, and storage tolerance, should not be affected by electrolyte 
or pH and be non-toxic. The formation of aggregates which in turn leads to the 
caking of solids would be the problem of suspension at the higher concentration. 
Reduction in the particle size or viscosity could not prevent caking. Caking can be 
prevented by flocculation and electrostatic stabilization [19, 20]. Kibbe showed 
that the increase in the stability of suspension using kaolin and talc as suspending 
and anti-caking agent. A suspension of pectin containing MAS dispersed in water 
along with kaolin under constant agitation at 70°C to which pectin was added, CMC 
was used to modify viscosity [17]. The usage of MAS and its four types (IA, IB, IC, 
and IIA) as a suspending agent has been commercialized and recognized by phar-
macopeias, as they do not affect the pourability or spreadibility of the suspension. 
Sarfaraz [17] reported the usage of magnabrite S (10 mg/ml) and magnabrite K 
(15 mg/ml) in bismuth sub-salicylate suspension in which smooth gel was obtained 
as a final product. The usage of MAS (veegum HV) as gelling agent was studied by 
Sarfaraz [17] and Vanderbilt report [21]. Vanderbilt report also suggested that the 
gelling property of veegum HV was affected by acids and improved by alkalies. An 
antacid suspension with veegum HV was prepared by Sarfaraz [17] using xanthan 
gum to modify viscosity. Schott [22] optimize the concentration of bentonite as 
suspending agent and concluded that the concentration between 0.5–5% w/v was 
suitable for formulations. Bismuth subnitrate suspension produces good floccula-
tion at 1.7% w/v of bentonite.
Many semisolid formulations use phyllosilicate as suspending agent due to 
their good adsorptive capacity which can be further improved by heating [23]. In 
many semisolid topical formulations, surface activated kaolin is added to enhance 
the stability and water miscibility of hydrophobic drug. Pharmaceutical prepara-
tion such as kaolin and morphine oral suspension BP, Toxiban suspension use 
kaolin as suspending anti-caking agent. The effect of crystallinity of kaolin on 
aqueous suspensions was studied by Ndlovu et al. Due to their dominant negative 
charge and ability to create permanent electrostatic repulsion justify kaolin use in 
suspension. The effect of non-ionic surfactant noigen RN10 (polyethylene alkyl 
phenyl ether) on kaolin wettability and stability was also studied. Clay can also 
help in stabilizing the suspension by having the effect on its rheological property 
since viscosity determines the rate of sedimentation according to stokes law. The 
different types and amount of clay are used to determine the final rheological 
property of the suspension. Dispersions showing dilant behavior contains 1:1 clay 
minerals and the pseudoplastic behavior is exhibited by 2:1 clay minerals. The 
commercialized MAS is a fibrous 2:1 clay containing blends of montmorellonite 
and seponite [6, 24, 25]. A combination of polyethylene glycol with hectorite 
improved the suspension stability [26, 27]. The modified hectorote such as qua-
ternary C18 hectorite, Steralkonium hectorite is used in organic media to control 
viscosity [28].
The use of clay along with polymers has shown beneficial effect on their rheo-
logical properties, which has been demonstrated in griseofulvin suspension with 
MAS and sodium alginate by Dechow et al. [29] in sulfamethoxazole/trimethoprim 
suspension. The synergistic effect of CMC on properties of MAS such as viscosity, 
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electrolyte tolerance, smooth flow property has led to the development of Veegum 
PLUS [30]. A similar synergism has also found in xanthan gum [31, 32].
2.1.2 In emulsion
Clay minerals are also added to pharmaceutical emulsion to prevent coalescence, 
creaming, phase inversion, breaking, and flocculation. This is due to their ability to 
wetted by the two liquid phases and be present as a barrier to prevent phase separa-
tion. Flocculation can be prevented by clay material due to their zeta potential. The 
stability of the emulsion is improved with increase in contact angle. They also used 
in the mechanical production of emulsion by acting as a surface acting agent which 
can bind in the interfacial layer but do not reduce the interfacial tension and inter-
face. Due to its higher surface area, talc has been used as a emulgent in the cosmetic 
preparation [18]. The use of bentonite as emulsifying agent is familiar throughout 
the cosmetic industry. A nail enamel cream contains bentonite as an emulsifier was 
prepared by Carter [33]. He also proposed specific method of the cream prepara-
tion. Vanishing creams and skin protectants also use bentonite in a concentration 
of 2.5% w/v as emulgent [34]. In order to aid in easy application and adherent 
effect on the skin surface, clay minerals are added in corn and callus emulsion [34]. 
They are also added to hand creams as a thickening agent to retain better moisture 
control. The viscosity of the liquid eye liner formulation is maintained by addition 
of veegum [34]. Purified bentonite (Polargel NF) has been used as an emulsifying 
agent in cleansing lotion with HPMC and benzoyl peroxide. This has also been 
prepared as a cream by the addition of viscosity building agent (Carbomer) [17]. An 
anti-acne cream emulsion is prepared by using MAS [17]. MAS is also incorporated 
in cream emulsions for burns, methyl salicylate (analgesic effect), astringent zinc 
oxide, zirconium oxide and in zinc undecylenate lotions as a emulsifying agent 
[17]. Certain vitamins enriched skin creams also use MAS as emulsifier [30]. The 
synergic effect of xanthan gum along with MAS has been seen in zirconium oxide 
lotion [17]. Wenninger et al. [35] showed the usage of palygorskite as an emulgent 
(2–5% w/v). The presence of Na+ and K+ ions in halite and slyvite and their ability 
to control micelle size enumerate their use as emulsifying, thickening and anti-
caking agent [36]. The long-term stability of pickering emulsions (where dodecane 
is used as oil phase) is improved by addition of kaolin (15% w/v) without any other 
additives [37].
2.2 Use of clay as an excipient in solid dosage forms
2.2.1 As diluent
Pharmaceutical oral preparations contain excipients such as diluent, flavorant, 
binder, disintegrant, pelletizing agent, granulating agent, sweetening agents, film 
coating agent, lubricant, and desiccants. Each excipient has its own influence on 
the formulation without interfering with active drug. It enhances the organoleptic 
and physiochemical property of the formulation. Diluents are selected based on 
the water solubility and bioavailability of active drug. Formulations with less 
water soluble drugs are incorporated with water soluble diluents and vice versa. 
Kaolin exhibit non-hygroscopic nature and low moisture content which deter-
mines its effectiveness as a diluent, as high moisture content may affect com-
pressibility, physical and chemical stability of the formulation. Physiochemical 
parameters of kaolin have a direct impact over compressibility of the formula-
tion [38]. The usage of kaolin as excipient for their adsorbent capacity has to be 
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properly maintained since high adsorbent capacity can lead to less bioavailability 
of the drug [38–40]. Diluents are mainly added to the formulation to bulk up the 
volume and to facilitate easy compression. Diluents account for the 90% in low 
dose formulation. Product such as slim-well and quantrim use kaolin as bulking 
agent whereas mecysteine hydrochloride (Gastro resistant tablet) has heavy grade 
kaolin. Riclasip and co-amoxyclav DST grunenthal uses kaolin as adjuvant [41]. 
The use of kaolin with metronidazole (antibiotic and antifungal drug, Riazole) 
reduces its bioavailability, release characteristic and diffusion of drug inside the 
body [42]. The absorption of D, L-phenylalanine (analgesic and anti-depressant) 
onto the slurry of colloidal kaolin was showed by Bonner and Flores [43] through 
in vitro gross adsorption chromatographic study. Kaolin also affect the bioavail-
ability of drugs like phenytoin (anti-seizure drug), promethazine-HCl (sedative 
and antiallergic drug), chloroquine (anti-malarial), propranolol (vasodilator), 
quinidine sulphate (cardiac antiarrhythmic drug), phenothiazines (trifluopera-
zine, fluphenazine, perphenazine, and thioridazine), guanethidine and hydrala-
zine (antihypertensive drugs), procainamide and verapamil (antiarrhythmic 
drugs) with antidiarrheal Kaopectate® drug [44–49]. It has been reported that 
Langmuir isotherm was followed in drug absorption by kaopectate which extent 
the bioavailability but the rate of drug availability is retarded. The double layered 
adsorption pattern of mebeverine hydrochloride (antispasmodic drug) with 
kaolin and added electrolytes again follows Langmuir isotherm was studied by Al 
Gohary. These types of interactions of kaolin can be prevented by increasing the 
ionic strength of the drug solution and with the presence of –NH2, –O–, and ben-
zene ring, as chelating ligands led to the interaction. The presence of di-aromatic 
ring in naproxen (anti-inflammatory drug) and siloxane surface of kaolin are 
responsible for their interaction [50]. On other hand, the absorption of ampicil-
lin and warfarin (anticoagulant) with antidiarrheal kaolin-pectin is shown to be 
unaffected by kaolin [51, 52], which was again conformed by Khalil et al. [53]. In 
fact, the use of kaolin as diluent in water soluble cationic riboflavin (vitamin B2) 
has improved the release rate of drug from hard gelatin capsule than any other 
diluents used. The rate of drug release is pH dependent [54]. The sustained release 
formulation of pyridoxine hydrochloride (vitamin B6) was prepared by using 
kaolin as diluent [55]. Vitamin drugs degrade easily in the presence of high mois-
ture content since kaolin exhibit low moisture content the formulation containing 
vitamin B1 (thiamine) and Vitamin C (ascorbic acid) is more stable on addition of 
kaolin than other additives [56, 57].
2.2.2 As binders
Binders help to maintain the physical integrity of the solid dosage form owing 
to their mechanical strength. They also play a vital role in granulation, tablet-
ing, encapsulation by acting as a homogeneous dispersed matrix for adhesion of 
all material in the formulation. On this context, the mixture of kaolin-Eudragit 
(8% w/w) has been one of the good binders for tableting process. Eudragit is a 
poly ester based resin which exhibit hydrophilicity and does not get affected by 
varying pH and also the presence of kaolin help to obtain a uniform polymeric 
dispersion by differentiating water insoluble and hydrophilic particle within the 
system. Irrespective of their physiochemical properties, hydrophilic drugs are 
also blended with low water soluble drug in the kaolin-Eudragit formulation due 
to their larger permeability. Based on kaolin concentration they can also be used 
as film coating agent [58, 59]. Minerals like periclase, calcite, and magnesite are 
added as binders to increase the stomach pH [60].
Clay Science and Technology
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2.2.3 As disintegrant
The release of drug from the formulation once it reaches inside the body mainly 
depends on the nature of the disintegrant used during formulation. Disintegrant 
facilitate breakdown of solid dosage form into smaller particulates. Poor solubility, 
poor gel forming capacity, good hydration capacity, good molding, flow property, 
and should not form complex are the required criteria for disintegrants. Both 
swelling property and ability to decompose at acidic environment of smectite made 
its use as a disintegrating agent. The presence of negative charge and ability to 
produce permanent negative surface charges helps kaolin as a disintegrant [61, 62]. 
A mixture of kaolin with surfactant and cellulose when added to formulation which 
already has starch as a disintegrant increased its shelf life over a long period of time 
[63]. Later, the use of kaolin as a positive effect than starch as a disintegrant has 
been proved [64].
2.2.4 As pelletizing agent
Kaolin proved its efficiency over bentonite by forming pellets which show faster 
disintegration while the pellets formed by bentonite was only erodible not disin-
tegrable [65]. Kaolin along with biopolymer increase the drug dissolution rate of 
hydrochlorothiazide by forming pellets that rapidly disintegrated into the dissolu-
tion medium [66]. The primary aim of pelletizing agent is to form microspheres 
of uniform size which can be compressed into tablets or filled into capsules that 
rapidly disintegrates inside gastrointestinal drug where each pellet act as sustain 
formulation [67, 68]. Kaolin as a pelletizing agent in comparison with bentonite, 
talc, veegum and bentonite produce pellets with maximum yield, desirable size and 
smooth pellets on addition of SLS (5%) over the others [69]. The beneficial effect 
of crospovidone (5% w/w) and kaolin (25% w/w) with lactose as pelletizing agent 
for enhancing roundness and sphericity of pellets was demonstrated by Kristensen 
et al. [65]. The drug dissolution rate of riboflavin was higher with kaolin than 
microcrystalline cellulose and lactose [66]. Desirable size range and sphericity can 
be obtained by incorporating high kaolin content. Aerosil 200 (5%) along with 
kaolin (45%) has huge positive impact on sphericity of pellets [70]. The granulating 
agent is added to the formulation to improve flow property, density, appearance 
and uniform drug content, they also aid in compressibility of oral formulation. 
Wet and dry granulations are most commonly used method of granule preparation. 
Wet granulation involves wetting, nucleation, coalescence, breakage, and attrition 
process whereas dry granulation involves direct compression or slugging [71, 72]. 
Granules of desirable strength, size, cohesion, and uniformity can be produced 
by mixture of kaolin and sodium chloride (10% w/w) in wet granulation process. 
The comparative study of kaolin with polyethylene glycol and polyvinyl alcohol as 
a binder in calcium chloride showed kaolin PVA mixture gave larger yield and size 
than PGA kaolin mixture [73].
2.2.5 Aid in solubility, dissolution, and lubrication
Kaolin also helps to convert drugs form their crystalline to amorphous state to 
improve their solubility, dissolution rate, and bioavailability [74–76]. Kaolin was 
added to ibuprofen in order to convert it to amorphous salt from its crystalline form 
to facilitate higher dissolution and bioavailability in comparison with standard. Halite 
can be used to control osmolarity of the solution due to their high solubility in water 
[77]. Amorphization is inversely proportional to the kaolin concentration [74]. Clays 
are also used as desiccants due to their hygroscopic nature. Talc is used as lubricant and 
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to prevent adhesion of powder to the compression pistons due to their soft and unctu-
ous nature [78]. They are also used as flavorant to mask the taste of the formulation.
2.2.6 As coating agent
The use of film coating additive enhance the organoleptic characters of solid 
dosage form, helps in maintaining stability and control drug release profile [79, 80]. 
The decrease in the rate of drug release of diphenhydramine chloride, theophylline, 
and pseudoephedrine hydrochloride pellets coated with Eudragit on addition of 
kaolin (3:1 of resin) was studied by Ghebre-Sellassie et al. [58]. Kaolin is also added 
to the film coating of hypericon and kollicoat IR. Kaolin incorporated on the outer 
shell of triple pressed dyphylline coated tablets showed control release [81].
2.2.7 Enhancer of organoleptic properties
The organoleptic property of a drug can be modified on addition of excipients 
like pigments and opacifiers into tablets, capsules, syrups, and topical creams. 
These are necessary to avoid confusion while administering multiple medications 
and for easy identification of different dosages and help to protect the drugs from 
photo-oxidative damage. Clay minerals (calcite, rutile, hematite, and magnesite) 
possess a wide range of color from red, green, black, yellow, and white. Coloring 
E171 is most used pigment which is a synthetic analogue of white zincite. Synthetic 
rutile is used on sunscreen lotion as opacifier.
3. Use of clay as an active ingredient
Clay minerals also has its application as active ingredient in pharmaceutical prepa-
ration due to their ability to act as antacids, antianemics, mineral supplements, gastric 
protectors, laxative, antidiarrhoeaics, antibiotics, antiviral agents, wound dressing 
agent, detoxifier, antitumor agent, anti-inflammatory, and tropical analgesic.
3.1 Antacid
Acidity is caused by excess secretion of HCl in the stomach due to various 
conditions. Clay minerals overcome acidity either by neutralizing hydrochloric 
acid or by decomposition of minerals by absorbing H+ ion on to their surface. Thus, 
restoring the stomach pH to 7 from 1.5 to 2.5. An effective antacid must increase the 
pH by three to four units and decrease the free acidity, which is seen in clay minerals 
like calcite, magnesite, periclase, brucite, and hydrotalcite. Whereas palygorskite, 
sepioite, montmorillonite, and saponite neutralize acidity by absorbing H+ ion 
onto their surface. Their usage also can lead to certain side effects such as renal 
silica calculi, constipation in case of over accumulation of Ca2+ since they form 
insoluble hydrate phosphate and Mg2+ ion produces laxative effect but these effects 
can be avoided by using different mineral compositions. This combination has also 
an advantage of sustaining the drug release for example the co-administration of 
gibbsite with brusite prolonged its antacid action since brusite is fast acting and 
gibbsite is slow acting antacid [82].
3.2 Wound dressing agent
Wounds characterized by skin abrasion and vascular damage can lead to micro-
bial invasion, toxicity, and even hemorrhagic shock due to uncontrolled bleeding. 
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This is countered by our body homeostatic response through coagulation of blood 
which prevents bleeding. Hemostasis follows sequential steps like: (1) thrombin 
formation is initiated, (2) activation and platelet aggregation (amplification), and 
(3) fibrin formation to stabilize the platelet clot (propagation). Hemostatic agents 
provide a physical mesh-like layer which aid in amplification and propagation steps 
of hemostasis thus leading to platelet aggregation and coagulation. The negative 
surface charge of kaolin at blood and plasma pH has a drastic effect on its blood 
clotting potential. The activation of blood coagulation factor XII to its active is 
done by kaolin on contact with blood and plasma. The active form of factor XII 
in turn activates factor XI and pre-kallikrein which helps in preventing bleeding. 
Therefore, many wound dressing products contain kaolin as topical hemostatic 
agents (Quickclot combat GauzeXL, Quickclotinterventional™) [83–87].
3.3 Peptic ulcer
Peptic ulcer is characterized by thinning of mucosal layer of the stomach due 
to the mucolytic activity of stomach enzymes, in order to reduce gastric irritation 
and provide a barrier for mucosal layer several clay minerals are used for their 
high sorption capacity and non-toxicity. These clay minerals absorb all the gases, 
toxins, bacteria and even viruses and reduce gastric secretions. They also act as 
protectants decreasing the glycoprotein degradation in the stomach. But their non-
specific action has led to their minimal usage. Even though smectites prevent the 
pepsin damaging activity over the mucosal layer, their very less time of action and 
tendency to get degraded in the acidic medium has been a disadvantage but kaolin 
can be stable and show very low dissolution even at very less pH. They are taken as 
tablets, suspensions, or powders orally. They dissolve easily in the acidic medium 
aiding in their easy elimination and absorption [82, 88–90]. Kaolin due to their 
higher sorptive capacity delay gastric emptying and intestinal transit by enhancing 
triacylglycerol hydrolysis and promoting the intestinal uptake of non-esterified 
fatty acid and glucose [91].
3.4 Anti-diarrheal agent and anti-emetics
Kaolin has been used as an API in formulations for gastrointestinal like ASDA 
stomach upset tablets, Entroclam, or Boots kaolin [92, 93]. Diarrhea is caused by 
various factors like allergy, bacterial infection, intoxication, and low efficiency of 
intestinal sorption. It is characterized by increase in fluidity and frequency of evac-
uation. Anti-diarrhoeaics agents must have very good absorption capacity of excess 
water as well as gases in the digestive tracts. Activated clay minerals like kaolinite, 
palygorskite, sepiolite, and montmorillonite can be used against diarrhea for their 
high sorption capacity. They also prevent diarrhea by forming in soluble salts 
through release of Ca2+ (calcite) and Al3+ (gibbsite) ions [94–97]. Pharmaceutical 
products such as kaolin/pectin (Kaopectate®) and Kaomix® suspensions, kaolin 
Antacil®, Sainsbury’s Diarrhea relief® and Treda® tablets contain kaolin as active 
ingredient against diarrhea due to hydrophilicity, surface area, microporosity, 
water osmotic and retention property as well as its antibacterial and antiviral effect 
(e.g., Norwalk and rotavirus, salmonella, Shigella and Escherichia coli bacteria) 
[98–101]. Minerals rich in Mg2+ or Na+ ion (mirabilite, epsomite, brucite, periclase, 
and magnesite) can act as laxative by increasing the osmatic pressure of the intes-
tinal content which induces water level increase in the intestine and finally produc-
ing liquid feces. They are given as solutions, granules, and suspensions, and these 
ions are mostly excreted through fecal matter and a small amount through kidney 
or bile duct. Halite and sylvite are administered as saline through oral or parental 
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route for the purpose of electrolyte replenishment (Na+ and K+). They are excreted 
through urine. Minerals rich in Cu2+ and Zn2+ (chalcocite, goslarite, and zincosite) 
can irritate gastric mucosa and trigger vomiting so they are used as direct emetic 
agents. When they reach intestine from stomach, they cause diarrhea. They are 
given orally as solutions. It can also be used to treat metal poisoning by removing 
them through vomit.
3.5 In anemia and inflammation
The use of clay minerals extents till its usage in disease like anemia. Anemia is 
caused due to less production red blood cells which may be due to less availability 
of Fe2+. This can be treated with melanterite which is rich in Fe2+ ion and read-
ily soluble in water. They are given as oral solution; these ions on reaching blood 
plasma convert into ferric ion by binding with a transferrin and globulin β. The 
excession is stored in liver, spleen, and bone marrow. Some are excreted through 
urine, gall bladder, and bile duct. Orally administered halite, epsomite, brucite, 
periclase, calcite, hydroxyapatite, magnesite, sylvite, melanterite as tablets provide 
ions such as Ca2+, Na+, Ca2+, Fe2+, K+, PO4
3−, and Mg2+ which are very much essential 
to our body [82]. Inflammatory response in our body is triggered to produce white 
blood cells and their mobility towards the injured site from infection through 
antigens or other harmful micro-organisms. Swelling, redness, pain, and heat are 
the main symptoms of inflammatory response. Lopez-Galindo and Viseras [102] 
presented the use of kaolinite poultices as anti-inflammatory drug, since they can 
absorb the excess fluid content near the infected tissue, which reduces pain and 
congestion considerably. They also aid in skin cooling by acting as a heat retention 
agent. Proper care of temperature must be taken while administering these dosages 
since it can have an effect over its therapeutic action [103–108].
3.6 Anti-bacterial
Minerals like sulfur, goslarite, borax, zincosite, chalcanthite, zincite, and alum 
are highly corrosive and toxic to pathogens in higher concentration hence they 
can be used as an antiseptic or disinfectant. They are also used as an astringent 
(chalcanthite), bacteriostatic agent (borax), fungicide, hemostatic agent (alum), 
and for skin damage. The bactericidal activity of clay extents to many drug resis-
tant bacteria like Pseudomonas aeruginosa, E. coli, and Staphylococcus aureus due to 
their physical and chemical properties that help them to envelope bacterial cells 
and interrupting their nutrient uptake, this is due to their high surface attraction 
towards the bacterial cell wall. Ions present in clay minerals also play an important 
role in their bactericidal property. Divalent cations like Cu2+ and Fe2+ are easily 
transferred and oxidized inside the bacterial cell to produce intercellular hydroxyl 
radicle which are lethal to them. The tri- or tetravalent cations show their activity 
inhibiting the influx or efflux pumps. Many modified clays have been reported to 
have good bactericidal activity, for example the photocatalytic activity of zinc oxide 
and Ti make TiO2 (ZnO)/kaolinite make the effective against Enterococcus faecalis, E. 
coli, and Pseudomonas aeruginosa. Moreover, Pseudomonas aeruginosa is also suscep-
tible to kaolin modified with CTAB and Cu. Oral pathogens like E. coli, Bacillus sub-
tilis, and klebsiella pneumonia are effectively killed by kaolin/iron-porphyrin hybrid. 
Nano-composite of silver-kaolinite also demonstrated to have antibacterial property 
[109]. They use clay as an adsorbate to remove pathogenic viruses and certain 
phages are under investigation since the twentieth century. First it is thought that 
viruses by electrostatic interaction are adsorbed onto the clay surface due to their 
valency associated cations and cation exchange capacity but later studies showed 
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that amino acid and carboxylic residue present on the outer shell viral protein coat 
is responsible for the net charge and their adsorption into clay minerals depends on 
pH, ionic strength, and isoelectric points of the clay and virus. Further studies show 
that hydrophobic interactions of crystallized kaolin show greater affinity for certain 
bacteriophages. In vitro studies of kaolin against hepatitis C virus, human enteric 
pathogenic adenoviruses (hAdVs) and adenovirus (HAdV-5) proved kaolin to be 
an effective material that could be used against certain viral infections [110]. Many 
substances like heavy metals, toxins, mycotoxins, and overdosed drug compounds 
can be removed from the gastrointestinal tract by administering kaolin as a detoxi-
fying agent.
3.7 Miscellaneous
Kaolin is found to influence superoxide radicle generation by immunocompetent 
carcinoma blood cells of Lewis lung in mice this opens a huge area of application 
for kaolin usage in restorative cancer treatment. Their antitumor property has 
made it a potential candidate under investigation [92, 100, 110–112]. Minerals like 
zincite, talc, rutile, hydrozincite, smithsonite, kaolinite, and smectites are used 
as an protective agent in skin to prevent against certain external environmental 
condition and pathogens. They have suitable properties like high sorption, non-
cytotoxic, little antiseptic and bactericidal as discussed above. They are used as 
creams, powders, and ointments (REINOL drygard, DP1, kerodex 51, etc.). They 
are also incorporated in sunscreen formulation to prevent against harmful UV-A 
and UV-B. Minerals like rutile and zincite absorb, reflect, and scatter the radiation 
but they may cause skin damage by photocatalytic action this can be overcome by 
using kaolin as protectant since it shows higher UV protection capacity due to the 
high Fe2O3 content. Kaolin also used to absorb excess moisture, oily secretion, sur-
face lipids, and superficial toxin from the skin surface to prevent acne, blackheads, 
bacterial, and fungal infections. Even they are used for insect bites to give relieving 
effect [109].
3.8 Skin protectant
Sulfur containing minerals are extensively used as keratolytic reducers as they 
are effective against dermatitis, eczemas, and psoriasis. Sulfur reacts with cysteine 
in the presence of keratinocyte producing hydrogen sulphide which breaks down 
keratin. Dandruff is treated with cadmium sulphide shampoo. The less common 
adverse effect of sulfur applied as topical cream is an added advantage [82]. Isotonic 
collyrium contains dissolved halite which is used as decongestive eye drops for 
treating eye dryness, irritation, and other ocular discomforts.
4. Use of clay as a drug delivery system
An effective drug delivery system is essential for achieving proper bioavailability 
of the drug administered. Recent studies have paved way for many new modified 
drug delivery system that has led to sustained drug deliver, controlled drug deliv-
ery, and site-specific drug delivery (Table 2). Each has its own mode of release 
and application in the body. The modification can be made only through excipients 
employed. The proposed excipients must possess good delivery efficiency at the 
same time have inertness, easy availability, cost effective, and low toxicity. Thus, 
all these are readily available in clay minerals and their physiochemical properties 
make them a potential candidate for design of MDDS. Clay minerals either in their 
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native form or modified in certain way to improve their physiochemical properties 
to aid their use as a drug carrier for delivering system.
4.1 As release retardant
Kaolin (1:1) and smectite (1:2) are the most common used clay groups in the 
design of MDDS due to their geometrical structure. The side effects like short 
half-life and requirement of frequent dosage in diclofenac sodium (NSAID) can 
overcome by intercalating it with MMT that prolong drug release. The toxicity 
of topically administered chlorhexidine (antibiotic) can be prevented by using 
Na-MMT as a drug delivery carrier. The photolytic damage of promethazine 
(antihistamine) when administered topically is reduced by intercalation of drug 
with Na-MMT. The in vitro activity and controlled release of paclitaxel (anti-
cancer) is increased by intercalation with Na-MMT and coating with chitosan 
(biopolymer). Gallic acid has various properties like poor solubility, permeability, 
and faster metabolism which make it difficult for dose administration and drug 
release. The idea of Gallic acid with MMT was suggested and carried to and char-
acterized the drug release profile which showed promising results. A dermal patch 
prepared using MMT-Na loaded with silver (antimicrobial agent), lidocaine (mild 
analgesic), and betaine hydrochloride showed a controlled release of lidocaine. 
The controlled drug release of metformin with Na-MMT was studied in order to 
reduce the side effect and dosage of drug. But the study concluded that the drug 
release was highly pH dependent and needed further analysis. MMT enhanced the 
antibacterial activity with TiO2 coated with alginate against both gram positive and 
negative bacteria. Mesalazine (5-Aminosalicylic acid) must reach colon to show 
its therapeutic action against Crohn’s disease but mesalazine is highly absorbed 
in the acidic environment of stomach. This can be altered and slow drug dissolu-
tion in stomach was achieved using MMT-Na encapsulated into alginate beads. 
Acidification improves clay surface area and increases pores for sorption. These 
acidified clays was used as a carrier to deliver ciprofloxacin, the acid treatment 
retarded the drug release due to the changes in the interlayer charges, this also 
provided insight on the usage of interlayer charge modifications of the clays can be 
a useful phenomenon for drug delivery. Silver nanoparticles are also loaded with 
modified clay and their antibacterial activity is characterized and a comparative 
study between modified and unmodified clay hybrid for their loading capacity and 
antibacterial activity against S. aureus and E. coli was done. The results showed that 
both the loading capacity and antibacterial activity was higher for acidified clay 
when compared to its native form. Periodontal extended release of tetracycline was 
achieved by intercalation of drug with MMT hybrid (Veegum HV) and chitosan as 
mucoadhesive base, the formulation required only once per week. Optimization of 
gentamycin loaded with another clay hybrid (Veegum F) was done and its antibac-
terial activity was evaluated, the formulation a delayed drug release up until 8 days. 
Theophylline was loaded onto MMT hybrid (Veegum F) to prevent the premature 
gastric drug absorption and to give a sustained release in intestine. Electrostatic 
interaction with clay hybrid prevents theophylline absorption at the stomach pH 
and facilitates slower absorption on the intestinal pH. The in vitro antibacterial 
activity of ciprofloxacin was determined by the type of interaction it forms with the 
clay hybrid, a weak interaction ensures easier release of drug into the desired site. 
Another modification of clay minerals which is used in MDDS is functionalization 
of the interlayers. One such functionalized clay is pillared clay which have large 
specific surface area and larger porosity due to the cationic exchange with inor-
ganic compounds (4-(dimethylamino)-1-(4-vinylbenzyl) pyridiniumchloride and 
1-methyl-3-(4-vinylbenzyl) imidazolium chloride). Ibuprofen loaded into MMT 
Clay Science and Technology
14
hybrid pillarized with Fe3+ and Fe2+ showed a delay in drug release under various 
physiological conditions. Doxorubicin (anticancer) was loaded into functionalized 
kaolin showed good drug loading efficiency and therapeutic action.
4.2 Clay-biopolymer combination
Biopolymers can also influence drug delivery by encapsulation or by surface 
coating over the formulation and help in controlled drug delivery. Hence, clay 
hybrids are coated with biopolymers to enhance their action. Clay hybrid and bio-
polymer (chitosan) showed synergistic effect on loading efficiency and drug release 
of 5-aminosalicylic acid. The oral bioavailability of oxytetracycline (broad spec-
trum antibiotic) was improved by loading over chitosan-MMT carrier. The cyto-
toxicity of chlorohexine to fibroblast was reduced by preparing a film carrier made 
of MMT-chitosan complex. The prepared topical formulation showed a controlled 
release of drug and reduction of cytotoxicity was also reported. MMT-chitosan 
glutamate composites also reduced the cytotoxic effects of silver sulfadiazine 
(skin burns). The result show that electrostatic interaction of MMT with polymer 
helps improving the drug absorption and the increase an antibacterial activity of 
formulation was also noted. Apart from chitosan, other biopolymers have been 
used to prepare drug carriers. A combination of guar gum-MMT hybrid was used to 
prepare a controlled release formulation of ibuprofen to reduce their side effects on 
intestinal tracts. The need of frequent dosage of venlafaxine (anti-depressive drug) 
was reduced by preparing beads with crosslinking of sodium ALG with drug-MMT 
in CaCl2. Olanzapine (schizophrenia and bipolar disorder) was incorporated into 
different polymer composition and their drug release at different pH was studied 
and the results were in comparison with the marked drug and an effective con-
trolled release was obtained by cloisite-drug with a blend of polymers (Alginate 
and xanthan gum). The solubility of curcumin (anticancer, anti-inflammatory 
and antibacterial agent) can be increased by dispersing the drug with CMC and 
loading into MMT, the role of MMT here is to improve the drug release in the acidic 
environment. A transdermal DDS was prepared from MMT nanocomposite, pectin, 
and methyl cellulose which is used to load ketorolac (NSAID). The formulations 
showed immediate release of drug from the nanocomposite layer but the increase in 
MMT showed controlled drug release. The PLA microspheres of 6-mercaptopurine 
(anticancer drug) with MMT showed a faster release rate and increased the drug 
solubility. The presence MMT also helps to control the drug release. The perfor-
mance of a pH dependent swelling polymer (poly acrylamide-co-maleic acid) was 
improved by the addition of MMT hybrid, it exerted a control over the caffeine drug 
release even during sudden pH transitions. A prolonged oral DDS was prepared 
for 1,3,4-oxa(thia)diazole (antifungal, antibiotic, analgesic and anti-inflammatory 
agent) by preparing nanocomposite using MMT hybrid. A site specific DDS was 
developed using MMT-polymer hybrid for anticancer treatment by co administra-
tion of doxorubicin and methotrexate with ciprofloxacin (antibiotic). Specificity of 
the DDS depends on the pH of the tumor cells. The results showed that the entire 
three drugs exhibit delayed drug release, where the anticancer drugs showed similar 
release profile and ciprofloxacin showed a different release profile at pH 5.8 and 4. 
PLGA is another biopolymer which is extensively used as carrier for drug adminis-
tration. A double emulsion of atenolol with PLGA and MMT was prepared by Lal 
and Datta to increase the half-life and dissolution rate of the drug. The result sug-
gested a controlled drug release in both acidic as well as basic medium with mark-
ing changes in the acidic medium. The hydrophobic drug (dexamethasone) was 
also intercalated with PLGA and MMT by Jain and Datta to lower the risk of side 
effects and achieve effective plasma concentration at minimal dosage. PLGS-MMT 
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nanocomposite is used as a carrier for insulin. In vitro studies by Lal et al. suggested 
the protective nature of MMT even in acidic conditions and also they do not affect 
the HEK-293 cells growth. A triblock (PCLA-PEG-PCLA) copolymer hydrogel of 
MMT-gemcitabine (anticancer) was prepared for the intravenous administration 
of drug since the drug is metabolized rapidly and require high dose. In vitro drug 
release studies suggested that MMT significantly reduced the drug release and 
the side effects. Nanocomposite of MMT hybrid with HEMA was used to modify 
the dissolution profile of paracetamol by Bounabi et al. The inclusion of MMT 
improved the drug encapsulation of paracetamol in the PLA-drug nanocomposite. 
A site specific DDS was prepared for doxorubicin was prepared using MMT hybrid 
with PE-5000/PEG750 polymer. Organoclay (MMT-PVP hybrid) nanocomposite 
was used to encapsulate copaiba oleoresin a natural derivative used against endo-
metriosis. The nanocomposite showed effective controlled drug release at acidic 
pH. A polymeric composite (PVA, CS and MMT) was prepared to encapsulate 
5-flurouracil (anticancer) in order to compensate its poor oral absorption and rapid 
metabolism. The results also indicate that the drug loading efficiency and drug 
release depends on the MMT concentration. Clay minerals like halosite and fibrous 
phyllosilicates have MMDS application due to their tubular and ribbon shaped 
structure. For example, the Hal nanotubes can adapt to any morphology making 
them used for wide variety of applications in MDDS. Various antibiotic like cipro-
floxacin, chlorpheniramine, tetracycline, diphenhydramine has been loaded on to 
the hal nanotubes and investigated. Cationic exchange capacity and pH determines 
the drug loading capacity on to the hal nanotubes. Thermodynamic equilibrium 
also affect the drug loading in hal nanotubes as in the case of isoniazid (antitu-
berculosis drug). The immobilization of binase (RNase enzyme) which is used in 
the genetic treatment of cancer was done and an enhanced anticancer property 
was reported. Vancomycin and breviscapine has been loaded on to hal nanotubes 
by vacuum cycle and the resultant complex showed a sustained release of drugs. 
Amoxicillin loaded onto Hal nanotubes are combined with biopolymers (PLGA and 
Chitosan) and the drug release was studied the results suggest a sustained release 
is obtained on both formulations with and without biopolymers than biopolymer-
drug complex. PMMA was coated onto paclitaxel-hal nanotube complex to improve 
the anticancer activity of the drug. Volatile drugs are also adsorbed onto the clay 
minerals which help in preventing the evaporation of those drugs and retaining 
their therapeutic action. The volatile drug absorption of MMT, hal nanotubes and 
palygorskite was evaluated by loading carvacrol (treat skin lesions). Good adsorp-
tion was seen in palygorskite. Veegum HS and sepiolite improved the solubility and 
dissolution rate of praziquantel (treatment of schistosomiasis) in both acidic and 
basic environment. Higher dissolution was achieved by oxaprozin (Non-steroidal 
anti-inflammatory agent) on mixing it with clay hybrid of palygorskite and sepio-
lite modified with cyclodextrin. Curcumin was loaded with both functionalized 
clay and cellulose-MMT complex to improve its site specific action and synergic 
effect on wound healing. A phospholipid nanocomposite of hal nanotubes was 
prepared to achieve a sustained release of doxorubicin. The electrostatic interac-
tion and intermolecular hydrogen bonding between palygorskite and chitosan was 
studied for its usage as a drug carrier for 5-aminosalicylic acid. Sepiolite is also used 
with chitosan as drug carrier for tetracycline and cefazolin. In vitro studies show 
the swelling of gel is facilitated by chitosan whereas the drug release id controlled 
by crosslinking of polyvinylacryalate (PVA). The synergistic effect of hydroxypro-
pylmethylcellouse acetate succinate along with atorvastatin and celecoxib for colon 
cancer is due to their effective solubility in basic pH. The controlled release of drug 
in colon is achieved by the preparing microspheres of hal nanotubes and HPMCAS 
loaded with anticancer drugs.
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5. Pharmaceutical clay in share market
The clay minerals are exported worldwide for their various applications in 
construction and pharmaceutical preparations. Based of the application the clay 
mineral export is classified as tableware, sanitary ware, medicinal applications. The 
key minerals are bentonite and kaolin which accounts for major export. Bentonite 
is exported as sodium, calcium and sulfur bentonite. The global market demand of 
bentonite (Figure 2a and b) was 22.68 million metric ton by 2016 and estimated 
to be 25.15 Million metric ton by 2021 with a CAGR increase of 2.12%. The global 
market share of bentonite by 2017 was 1.43 billion and estimated to be increasing 
scale due to the market demand and increase in the applications of clay minerals. 
The major region of export is classified as Asia Pacific, North America, Europe and 
Rest of the world with Asia and North America accounting for most. The major 
companies exporting clay minerals are Ashapura groups (India’s major exporter), 
Imerys(sandB), Taiko group, Huawei Bentonite, Theile kaolin company, Kaolin 
A.D, J.M.Huber, Daleco resources.
6. Conclusion and outlook
From the moment of discovery clay minerals have been immensely useful to 
human life in both ceramic and health. Their usage in health care has made it a 
essential compound in many pharmaceutical preparations. Their inertness, low 
toxicity, versatile physiochemical properties and cost effectiveness has increased 
its usage in pharma industries. At the same time precautions must be taken while 
incorporating higher doses of clay and while co-administering clay with drug. Since 
some clay has been reported to reduce the efficacy and bioavailability of certain 
classes of drugs like antacid and in higher doses it might cause tissue toxicity. The 
understanding of surface chemistry and particle size distribution of clay minerals 
has led the pharmaceutical field in many directions and future perspectives. Their 
unique structure which helps them to absorb material onto their layered sheets 
has opened a wide variety of applications in drug delivery. Their ability to control 
and alter drug release profile can been exploited in many ways to design a effective 
drug delivery system. Further advancements in nanotechnology have helped to 
synthesize and modify this clay mineral to enhance their physiochemical properties 
and their usage as excipient. Though clay and their minerals are used in its natural 
Figure 2. 
(a) Bentonite classification based on minerals. (b) Bentonite usage on global demand scale.
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state for drug delivery, some require additional modification for their usage and this 
modification plays a key role in determining the economical aspect of drug design-
ing. The development of machinery which helps us to understand better about 
various unknown properties of clay minerals which were not understood before will 
aid us to utilize clay minerals in various other applications.
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